Published date: 28 May 2021
Withdrawn opportunity - This means that the contract has been withdrawn early. This could be due to a change of circumstances.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
SW1H 0EU
Value of contract
£76,931.50
Procurement reference
CF-0208300D0O000000rwimUAA1
Published date
28 May 2021
Closing date
16 April 2021
Closing time
12pm
Contract start date
20 April 2021
Contract end date
30 September 2021
Contract type
Supply contract
Procedure type
Competitive procedure with negotiation (above threshold)
Anyone may ask to participate, but only those who are pre-selected will be invited to submit initial tenders and to negotiate.
This procedure can be used for procurements above the relevant contract value threshold.
This is an accelerated procedure.
Justification
The Coronavirus disease (COVID-19) gave rise to an extremely urgent need for the Authority to purchase a quantity of Ascorbic Acid because the Authority needs to be in a position to treat the population as required such that did not give the Authority sufficient time to comply with the standard Open Procedure time scales for this procurement. Accordingly, the Authority used the negotiated procedure without prior publication - Regulation 32(2)(c) - Extreme Urgency Route (i.e. direct award) permitted under the Public Contract Regulations 2015 (as amended) to conduct this procurement. It was imperative to maintain security of supply for public health purposes in the face of high global demand. In these circumstances, a procurement following the usual timescales under the PCR 2015, including accelerated options, was not feasible in order for the Authority to secure the urgent Supply, Storage, Over-labelling and Distribution of Ascorbic Acid.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
The Department of Health and Social Care conducted a negotiated procedure without prior publication under the Public Contracts Regulations 2015 (as amended) for the Supply, Storage, Over-labelling and Distribution of Ascorbic Acid.
More information
Previous notice about this procurement
Supply, Storage, Over-labelling and Distribution of Ascorbic Acid
- Awarded contract
- Published 27 May 2021
Links
-
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kjXQ/T5kpj6_yl76t_vMq.kjepT0vshlrePk4SORtNYsvBAY
- Doc.3_Conditions_of_Contract_CM_EMP_20_12554 Clinigen DHSCv Final_Redacted
-
- https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kjXG/UvotE8hTofS8bSjihvexdxHoiQ5ixMRng7FQTFsP7K8
- DHSC_Mawdsley_Contract for Services Final Version 21042021_Redacted_v1
About the buyer
Contact name
Simeon Hadebe
Address
39 Victoria Street
Westminster, London
SW1H 0EU
United Kingdom
Share this notice
Closing: 16 April 2021, 12pm